Lonza primary, diseased primary and stem cells

Wednesday, 14 March, 2012 | Supplied by: Capsugel Australia Pty Ltd

Lonza primary, diseased primary and stem cells

Research shows that non-transformed, non-immortalised cells isolated directly from tissue provide conditions that closely simulate a living model and yield more physiologically significant results.

With Clonetics Primary Normal Cells and Media, Lonza provides over 150 authenticated primary human and animal cell types with optimised media for growth and maintenance.

With Clonetics Primary Diseased Cells, the company offers primary cells derived from patients with COPD, asthma, Type 1 and Type 2 diabetes.

The company’s Stem Cells and Media offer primary human adult stem and progenitor cells from bone marrow, cord blood and adipose tissue with growth and differentiation media, and ES-derived differentiated cells and media.

Lonza primary cells and media are tested together to guarantee performance. The company uses strict industry QC standards to ensure consistent performance on every lot manufactured.

All tissue utilised for the company’s human cell products is ethically obtained with documented and informed donor consent.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...

Echelon Biosciences ionisable lipids

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...

BioStatus CyTRAK Orange fluorescent dye

BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd